SCHEMBL30146627

SCHEMBL30146627

c1ccc(-c2cccc(-c3cccc(N4CCNCC4)c3)c2)cc1

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 10/20 0.96
HTR1A P08908 8/20 0.96
TP53 P04637 4/20 0.69
CYP1A2 P05177 4/20 0.69
CYP2D6 P10635 4/20 0.69
USP2 O75604 3/20 0.69
ALDH1A1 P00352 3/20 0.69
HSD17B10 Q99714 3/20 0.69
CYP3A4 P08684 3/20 0.69
MAPK1 P28482 2/20 0.69
TSHR P16473 1/20 0.69
ADRB1 P08588 3/20 0.66
HTR3E A5X5Y0 2/20 0.66
HTR3B O95264 2/20 0.66
HTR3A P46098 2/20 0.66
HTR3D Q70Z44 2/20 0.66
HTR3C Q8WXA8 2/20 0.66
SIGMAR1 Q99720 2/20 0.66
HIF1A Q16665 1/20 0.62
HTR2C P28335 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30022113 0.98 HTR7 (1.00) HTR7HTR1ATP53CYP1A2CYP2D6
SCHEMBL1914606 0.98 HTR7 (1.00) HTR7HTR1ATP53CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL29157433 0.96 HTR7 (0.96) HTR7HTR1ATP53CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL6786785 0.96 HTR7 (0.96) HTR7HTR1ATP53CYP1A2CYP2D6
SCHEMBL13118661 0.85 HTR7 (0.76) HTR7HTR1ATP53CYP1A2CYP2D6
SCHEMBL15577989 0.85 HTR7 (1.00) HTR7HTR1ATP53CYP1A2CYP2D6
SCHEMBL15538190 0.85 HTR7 (0.75) HTR7HTR1ATP53CYP1A2CYP2D6
SCHEMBL13118660 0.83 HTR7 (0.81) HTR7HTR1ATP53CYP1A2CYP2D6
SCHEMBL27497441 0.81 HTR1A (0.70) HTR7HTR1ATP53CYP1A2CYP2D6
SCHEMBL1359864 0.81 ADRB1 (0.76) HTR7HTR1ATP53CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179059-A1 ANTICANCER COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-06-05 US disclosed
US-12162870-B2 Anticancer compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-12-10 US disclosed
US-20230025178-A1 ANTICANCER COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179059-A1 ANTICANCER COMPOUNDS BET1, BRD4, BICRA HTR7 3578/4885HTR1A 4383/4885TP53 46/4885
US-20230025178-A1 ANTICANCER COMPOUNDS BET1, BRD4, BICRA HTR7 3578/4885HTR1A 4383/4885TP53 46/4885
US-12162870-B2 Anticancer compounds BET1, BRD4, BICRA HTR7 3578/4885HTR1A 4383/4885TP53 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.